Faisal A Torad - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Open Veterinary Journal|December 7, 2020

Feline aortic thromboembolism: Presentation, diagnosis, and treatment outcomes of 15 catsMarwa H Hassan, Ashraf M Abu-Seida, Faisal A Torad, et al.

Topics in Companion Animal Medicine|June 5, 2015

Canine neonatal transcranial ultrasonography from birth until closure of bregmatic fontanelleElham A Hassan, Faisal A Torad, Omar S El-Tookhy, et al.

Journal of Advanced Research|February 25, 2020

New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacyReham Waheed Hammad, Rania Abdel-Basset Sanad, Nevine Shawky Abdelmalak, et al.

AAPS Pharmscitech|October 4, 2018

Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic StudiesReham Waheed Hammad, Rania Abdel Baset Sanad, Nevine Shawky Abdelmalk, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Open Veterinary Journal|December 7, 2020

Feline aortic thromboembolism: Presentation, diagnosis, and treatment outcomes of 15 catsMarwa H Hassan, Ashraf M Abu-Seida, Faisal A Torad, et al.

Topics in Companion Animal Medicine|June 5, 2015

Canine neonatal transcranial ultrasonography from birth until closure of bregmatic fontanelleElham A Hassan, Faisal A Torad, Omar S El-Tookhy, et al.

Journal of Advanced Research|February 25, 2020

New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacyReham Waheed Hammad, Rania Abdel-Basset Sanad, Nevine Shawky Abdelmalak, et al.

AAPS Pharmscitech|October 4, 2018

Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic StudiesReham Waheed Hammad, Rania Abdel Baset Sanad, Nevine Shawky Abdelmalk, et al.

Pageof 2